Actively Recruiting
Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock
Led by University Hospital, Brest · Updated on 2024-08-27
50
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.
CONDITIONS
Official Title
Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (Age >18 years old)
- Septic shock according to Sepsis-3 definition, including suspected or confirmed infection
- Persisting hypotension despite adequate fluid resuscitation requiring vasopressors to maintain MAP 65 mmHg
- Lactate level > 2 mmol/l
- Predictive ICU length of stay > 3 days
You will not qualify if you...
- Admission in ICU for more than 3 days
- Refusal to participate
- Moribund patients
- Decision of therapeutic withdrawal
- Curators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Chu Brest
Brest, France, 29200
Actively Recruiting
2
Hegp - Aphp
Paris, France, 75015
Not Yet Recruiting
Research Team
X
Xavier Chapalain, MD
CONTACT
D
Dauphou Eddi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here